Lian, Jiangshan <br/><br/>
Prophylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virus.  [electronic resource] 

 -  Virus research  09 2019 
 - 197664 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7492 
<br/><br/><label>Standard No.: </label>10.1016/j.virusres.2019.197664  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antitubercular Agents--adverse effects<br/>Antiviral Agents--administration & dosage<br/>Chemical and Drug Induced Liver Injury--prevention & control<br/>Coinfection--microbiology<br/>Female<br/>Hepatitis B--drug therapy<br/>Hepatitis B virus<br/>Humans<br/>Incidence<br/>Liver--drug effects<br/>Liver Failure--prevention & control<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis<br/>Retrospective Studies<br/>Risk Factors<br/>Tuberculosis--drug therapy<br/>Young Adult